2010 Q2WEEK CONTROLLED-RELEASE-INTERFERON-ALPHA2B + RIBAVRIN REDUCES FLU-LIKE SYMPTOMS >50% AND PROVIDES EQUIVALENT EFFICACY IN COMPARISON TO WEEKLY PEGYLATED-INTERFERON-ALPHA2B + RIBAVIRIN IN TREATMENT-NAIVE-GENOTYPE-1-CHRONIC-HEPATITIS-C: RESULTS FROM EMPOWER, A RANDOMIZED-OPEN-LABEL-12-WEEK-COMPARISON IN 133 PATIENTS

✍ Scribed by Long, W.A.; Takov, D.; Tchernev, K.; Kotzev, I.; Rigney, A.; Krastev, Z.; Stoynov, S.; Balabanska, R.; Lawitz, E.; Younossi, Z.; Ghalib, R.; Zuckerman, E.; Safadi, R.; Tur-Kaspa, R.; Assy, N.; Lurie, Y.

• Book ID: 123170514
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 52 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(10)61201-9